These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
134 related items for PubMed ID: 7970086
1. Effect of aspirin and dipyridamole on proteinuria in idiopathic membranoproliferative glomerulonephritis: a multicentre prospective clinical trial. Collaborative Glomerulonephritis Therapy Study Group (CGTS). Zäuner I, Böhler J, Braun N, Grupp C, Heering P, Schollmeyer P. Nephrol Dial Transplant; 1994; 9(6):619-22. PubMed ID: 7970086 [Abstract] [Full Text] [Related]
2. Effect of acetylsalicylic acid and dipyridamole in primary membranoproliferative glomerulonephritis type I. Harmankaya O, Baştürk T, Oztürk Y, Karabiber N, Obek A. Int Urol Nephrol; 2001; 33(3):583-7. PubMed ID: 12230299 [Abstract] [Full Text] [Related]
3. [Treatment of chronic proliferative glomerulonephritis using acetylsalicylic acid and dipyridamole]. Knotková V, Petrů I, Nĕmecek K, Cieslar P, Pelèska J, Jáchymová M, Pick P, Tomasy M. Cas Lek Cesk; 1989 Jun 28; 128(26):814-8. PubMed ID: 2507156 [Abstract] [Full Text] [Related]
4. [Effect of cyclosporin monotherapy on proteinuria in a patient with membranoproliferative glomerulonephritis]. Matsumoto H, Shibasaki T, Ohno I, Sakai O, Kuriyama S, Tomonari H, Utsunomiya Y, Nakao T. Nihon Jinzo Gakkai Shi; 1995 Apr 28; 37(4):258-62. PubMed ID: 7602814 [Abstract] [Full Text] [Related]
5. Results of a controlled drug trial in membranoproliferative glomerulonephritis. Cattran DC, Cardella CJ, Roscoe JM, Charron RC, Rance PC, Ritchie SM, Corey PN. Kidney Int; 1985 Feb 28; 27(2):436-41. PubMed ID: 3886998 [Abstract] [Full Text] [Related]
6. C5 Convertase Blockade in Membranoproliferative Glomerulonephritis: A Single-Arm Clinical Trial. Ruggenenti P, Daina E, Gennarini A, Carrara C, Gamba S, Noris M, Rubis N, Peraro F, Gaspari F, Pasini A, Rigotti A, Lerchner RM, Santoro D, Pisani A, Pasi A, Remuzzi G, EAGLE Study Group. Am J Kidney Dis; 2019 Aug 28; 74(2):224-238. PubMed ID: 30929851 [Abstract] [Full Text] [Related]
7. Long-term corticosteroid and dipyridamole treatment of membranoproliferative glomerulonephritis type I in children. Takeda A, Niimura F, Matsutani H. Nihon Jinzo Gakkai Shi; 1995 Jun 28; 37(6):330-5. PubMed ID: 7666598 [Abstract] [Full Text] [Related]
8. Administration of aspirin-dipyridamole reduces proteinuria in diabetic nephropathy. Hopper AH, Tindall H, Davies JA. Nephrol Dial Transplant; 1989 Jun 28; 4(2):140-3. PubMed ID: 2496357 [Abstract] [Full Text] [Related]
9. Myeloid-related protein 8 expression on macrophages is a useful prognostic marker for renal dysfunction in children with MPGN type 1. Kawasaki Y, Hosoya M, Takahashi A, Isome M, Tanji M, Suzuki H. Am J Kidney Dis; 2005 Mar 28; 45(3):510-8. PubMed ID: 15754273 [Abstract] [Full Text] [Related]
10. Effect of dipyridamole with or without aspirin on urine protein excretion in patients with membranous glomerulonephritis. De La Cruz JP, Cámara S, Frutos MA, Sánchez De La Cuesta F. Eur J Clin Pharmacol; 1992 Mar 28; 43(3):307-9. PubMed ID: 1425898 [Abstract] [Full Text] [Related]
11. Membranoproliferative glomerulonephritis. A prospective clinical trial of platelet-inhibitor therapy. Donadio JV, Anderson CF, Mitchell JC, Holley KE, Ilstrup DM, Fuster V, Chesebro JH. N Engl J Med; 1984 May 31; 310(22):1421-6. PubMed ID: 6371535 [Abstract] [Full Text] [Related]
12. [The effect of acetylsalicylic acid and dipyridamole on glomerular filtration and proteinuria in chronic glomerulonephritis]. Nĕmecek K, Petrů I, Knotková V, Jáchymová M. Vnitr Lek; 1990 Apr 31; 36(4):324-9. PubMed ID: 2356608 [Abstract] [Full Text] [Related]
13. Management of membranoproliferative glomerulonephritis: evidence-based recommendations. Levin A. Kidney Int Suppl; 1999 Jun 31; 70():S41-6. PubMed ID: 10369194 [Abstract] [Full Text] [Related]
14. A comparative randomized and placebo-controlled short-term trial of aspirin and dipyridamole for overt type-2 diabetic nephropathy. Khajehdehi P, Roozbeh J, Mostafavi H. Scand J Urol Nephrol; 2002 Jun 31; 36(2):145-8. PubMed ID: 12028688 [Abstract] [Full Text] [Related]
15. Comparison of pulse and oral steroid in childhood membranoproliferative glomerulonephritis. Bahat E, Akkaya BK, Akman S, Karpuzoglu G, Guven AG. J Nephrol; 2007 Jun 31; 20(2):234-45. PubMed ID: 17514629 [Abstract] [Full Text] [Related]
16. Positive C1q staining associated with poor renal outcome in membranoproliferative glomerulonephritis. Takei T, Itabashi M, Moriyama T, Shimizu A, Tsuruta Y, Ochi A, Nakayama K, Iwasaki C, Uchida K, Nitta K. Clin Exp Nephrol; 2013 Feb 31; 17(1):92-8. PubMed ID: 22821391 [Abstract] [Full Text] [Related]
17. The relation between treatment and prognosis of childhood membranoproliferative glomerulonephritis. Çaltik Yilmaz A, Aydog Ö, Akyüz SG, Bülbül M, Demircin G, Öner A. Ren Fail; 2014 Sep 31; 36(8):1221-5. PubMed ID: 25065413 [Abstract] [Full Text] [Related]
18. Effect of fluvastatin and dipyridamole on proteinuria and renal function in childhood IgA nephropathy with mild histological findings and moderate proteinuria. Kano K, Nishikura K, Yamada Y, Arisaka O. Clin Nephrol; 2003 Aug 31; 60(2):85-9. PubMed ID: 12940609 [Abstract] [Full Text] [Related]
19. Treatment of membranoproliferative glomerulonephritis associated with hepatitis C virus infection. Niigata Research Group of Glomerulonephritis and Nephrotic Syndrome. Nishi S, Ueno M, Shimada H, Oosawa Y, Iino N, Iguchi S, Karasawa R, In H, Kawashima S, Saito N, Imai N, Saito K, Suzuki S, Arakawa M, Gejyo F. Intern Med; 2000 Oct 31; 39(10):788-93. PubMed ID: 11030201 [Abstract] [Full Text] [Related]